Skip to main content
Premium Trial:

Request an Annual Quote

BD s Atto Bioscience to Acquire Scanalytics for $453K

NEW YORK, July 1 (GenomeWeb News) - IT vendor CSP has sold the assets of its Scanalytics subsidiary to Becton Dickinson business Atto Bioscience for $453,000 in cash, the company said today.

Scanalytics, based in Fairfax, Va., markets scientific imaging software, including deconvolution and 3D restoration and gel analysis software. Atto Bioscience specializes in optical instrumentation, software, and reagents for real-time cell analysis.

The acquisition makes sense to BD. Most recently, BD Biosciences and Scanalytics signed an alliance to co-develop image-analysis software for BD Bioscience's automated microscopy platforms.


Dietrich Ruehlmann, BD Biosciences' product manager for imaging and analysis, told GenomeWeb News at the time that BD began the partnership with Scanalytics a few months ago with the goal of developing image-analysis platforms for BD Biosciences' CARV II Confocal Imager and Pathway Bioimager for high-content drug screening.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.